14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model

被引:20
|
作者
Underwood, Rachel [1 ,3 ]
Gannon, Mary [1 ]
Pathak, Aneesh [1 ]
Kapa, Navya [1 ]
Chandra, Sidhanth [1 ,4 ]
Klop, Alyssa [1 ]
Yacoubian, Talene A. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA
[2] Civitan Int Res Ctr, Room 510A,1719 Sixth Ave South, Birmingham, AL 35294 USA
[3] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Maloney Bldg,3rd Floor,3600 Spruce St, Philadelphia, PA 19104 USA
[4] Northwestern Univ, Med Scientist Training Program, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
14-3-3s; Alpha-synuclein; Parkinson's disease; Dementia with Lewy Bodies; Substantia nigra; Amygdala; Cortex; Mouse;
D O I
10.1186/s40478-020-01110-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alpha-synuclein (alpha syn) is the key component of proteinaceous aggregates termed Lewy Bodies that pathologically define a group of disorders known as synucleinopathies, including Parkinson's Disease (PD) and Dementia with Lewy Bodies. alpha Syn is hypothesized to misfold and spread throughout the brain in a prion-like fashion. Transmission of alpha syn necessitates the release of misfolded alpha syn from one cell and the uptake of that alpha syn by another, in which it can template the misfolding of endogenous alpha syn upon cell internalization. 14-3-3 proteins are a family of highly expressed brain proteins that are neuroprotective in multiple PD models. We have previously shown that 14-3-3 theta acts as a chaperone to reduce alpha syn aggregation, cell-to-cell transmission, and neurotoxicity in the in vitro pre-formed fibril (PFF) model. In this study, we expanded our studies to test the impact of 14-3-3s on alpha syn toxicity in the in vivo alpha syn PFF model. We used both transgenic expression models and adenovirus associated virus (AAV)-mediated expression to examine whether 14-3-3 manipulation impacts behavioral deficits, alpha syn aggregation, and neuronal counts in the PFF model. 14-3-3 theta transgene overexpression in cortical and amygdala regions rescued social dominance deficits induced by PFFs at 6 months post injection, whereas 14-3-3 inhibition by transgene expression of the competitive 14-3-3 peptide inhibitor difopein in the cortex and amygdala accelerated social dominance deficits. The behavioral rescue by 14-3-3 theta overexpression was associated with delayed alpha syn aggregation induced by PFFs in these brain regions. Conversely, 14-3-3 inhibition by difopein in the cortex and amygdala accelerated alpha syn aggregation and reduction in NECAB1-positive neuron counts induced by PFFs. 14-3-3 theta overexpression by AAV in the substantia nigra (SN) also delayed alpha syn aggregation in the SN and partially rescued PFF-induced reduction in tyrosine hydroxylase (TH)-positive dopaminergic cells in the SN. 14-3-3 inhibition in the SN accelerated nigral alpha syn aggregation and enhanced PFF-induced reduction in TH-positive dopaminergic cells. These data indicate a neuroprotective role for 14-3-3 theta against alpha syn toxicity in vivo.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts
    Mustafa T. Ardah
    Simona S. Ghanem
    Sara A. Abdulla
    Guohua Lv
    Mohamed M. Emara
    Katerina E. Paleologou
    Nishant N. Vaikath
    Jia-Hong Lu
    Min Li
    Konstantinos Vekrellis
    David Eliezer
    Omar M. A. El-Agnaf
    BMC Complementary Medicine and Therapies, 20
  • [22] Aggregation of alpha-synuclein in functional model membrane systems
    Corvaglia, Stefania
    Scaini, Denis
    Casalis, Loredana
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [23] Cellular Model for Spontaneous Initiation of alpha-Synuclein Aggregation
    Svanbergsson, Alexander
    Avallone, Martino
    Bjorklund, Tomas
    Li, Jia-Yi
    MOLECULAR THERAPY, 2020, 28 (04) : 142 - 142
  • [24] Evaluation of alpha-synuclein aggregation in a Parkinson mouse model
    Weber, Franziska
    Brunner, Janine
    May, Caroline
    Marcus, Katrin
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (05) : 683 - 683
  • [25] TARGETING THE CMA PATHWAY IN NEURONAL CELLS MITIGATES ALPHA-SYNUCLEIN INDUCED TOXICITY
    Xilouri, M.
    Peng, H. Y.
    Papasilekas, T.
    Vekrellis, K.
    Stefanis, L.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 53 - 53
  • [26] The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicity
    Plotegher, Nicoletta
    Kumar, Dhruv
    Tessari, Isabella
    Brucale, Marco
    Munari, Francesca
    Tosatto, Laura
    Belluzzi, Elisa
    Greggio, Elisa
    Bisaglia, Marco
    Capaldi, Stefano
    Aioanei, Daniel
    Mammi, Stefano
    Monaco, Hugo L.
    Samori, Bruno
    Bubacco, Luigi
    HUMAN MOLECULAR GENETICS, 2014, 23 (21) : 5615 - 5629
  • [27] PIP3 interacts with alpha-synuclein and initiates its aggregation of Parkinson's disease-related fibril polymorphism
    Ikenaka, Kensuke
    Choong, Chi-Jing
    Aguirre, Cesar
    Kakuda, Keita
    Mochizuki, Hideki
    JOURNAL OF NEUROCHEMISTRY, 2023, 166 : 78 - 78
  • [28] Similarity of the non-amyloid-β component and C-terminal tail of monomeric and tetrameric alpha-synuclein with 14-3-3 sigma
    Evans, Sarah R.
    West, Colista
    Klein-Seetharaman, Judith
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 5348 - 5359
  • [29] Dopaminergic Positron Emission Tomography Imaging in the Alpha-Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
    Sossi, Vesna
    Patterson, Joseph R.
    McCormick, Siobhan
    Kemp, Christopher J.
    Miller, Kathryn M.
    Stoll, Anna C.
    Kuhn, Nathan
    Kubik, Michael
    Kochmanski, Joseph
    Luk, Kelvin C.
    Sortwell, Caryl E.
    MOVEMENT DISORDERS, 2022, 37 (08) : 1739 - 1748
  • [30] Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson's Disease
    Duffy, Megan F.
    Collier, Timothy J.
    Patterson, Joseph R.
    Kemp, Christopher J.
    Fischer, D. Luke
    Stoll, Anna C.
    Sortwell, Caryl E.
    FRONTIERS IN NEUROSCIENCE, 2018, 12